Skip to main content
ALUMIS INC. logo

ALUMIS INC. — Investor Relations & Filings

Ticker · ALMS ISIN · US0223071020 US Manufacturing
Open in API
Filings indexed 210 across all filing types
Latest filing 2026-05-18 Annual Report
Country US United States of America
Listing US ALMS

About ALUMIS INC.

https://www.alumis.com/

Alumis Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing medicines for autoimmune and immune-mediated diseases. The company employs a precision medicine approach, leveraging a proprietary data analytics platform to advance its late-stage portfolio of next-generation targeted therapies. Alumis aims to replace broad immunosuppression with more specific treatments, seeking to optimize patient outcomes and address the limitations of existing therapies for a wide range of immune dysfunctions.

Recent filings

Filing Released Lang Actions
ARS
Annual Report FY 2025
2026-05-18 English
DEFA14A
Proxy Solicitation & Information Statement
2026-05-18 English
DEF 14A
Proxy Solicitation & Information Statement
2026-05-18 English
10-Q
Interim / Quarterly Report Q1 2026
2026-05-14 English
8-K
Report Publication Announcement Classification · 85% confidence The document is a Form 8-K current report that merely furnishes a press release as Exhibit 99.1 announcing Q1 financial results. It contains no actual financial statements or detailed earnings data, only a notice that the press release is attached. Under the “menu vs. meal” rule, it is not the earnings release itself but an announcement of its publication. Therefore the correct classification is Report Publication Announcement (RPA).
2026-05-14 English
8-K - ALUMIS INC. (0001847367) (Filer)
Regulatory Filings Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce unscheduled material events or corporate changes. The text indicates that Alumis Inc. issued a press release and filed slides from a presentation at a medical conference. The document includes forward-looking statements and references exhibits containing the press release and presentation slides. There are no financial statements or detailed financial data included, nor is this an annual or quarterly report. The document is not a certification or a voting result announcement. It is a regulatory filing to disclose other events and related materials. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length (8028 characters) and content confirm it is not merely a brief announcement but a full Form 8-K filing, which fits under RNS as a general regulatory announcement.
2026-03-30 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.